Discover how the integration of advanced practice providers in oncology is evolving and the principles that guide their essential roles in patient care. Source: NCCN.
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.